Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Corticosteroids in the prevention and management of bronchopulmonary dysplasia

Grier, David G, Halliday, Henry L · 2003 · Seminars in Neonatology

Abstract

Corticosteroids were first prescribed for preterm neonates to treat respiratory distress syndrome, but they were found to have no beneficial effect in this disorder. About 20 years ago, dexamethasone was first used to treat infants with bronchopulmonary dysplasia who were ventilator dependent after the age of 3 weeks. There were short-term benefits, with an improvement in lung function and a facilitation of endotracheal extubation. During the 1990s, corticosteroid treatment, mainly with dexamethasone in relatively high doses, became very common in neonatal intensive care units. Towards the end of the decade, however, follow-up studies provided evidence of abnormal neurodevelopment, especially in infants treated early (<4 days) with dexamethasone. The precise cause of these neurodevelopmental problems is unclear, but until further evidence has been obtained, the early use of dexamethasone cannot be recommended for preterm infants. This review attempts to provide evidence-based guidelines for postnatal steroid therapy in the management of chronic lung disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1084-2756(02)00189-6

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Research works printed but not linked: 7

  1. Halliday, 2001, Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review), Issue 3
  2. Halliday, 2001, Moderately early (7–14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review), Issue 3
  3. Halliday, 2001, Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review), Issue 3
  4. Ramanathan, 1996, Comparison of two dosage regimens of dexamethasone for early treatment of chronic lung disease in very low birth weight (VLBW) infants: a double-blinded, randomised trial, Pediatr Res, 37, 229A
  5. Cole, 1997, Role of postnatal steroids for chronic lung disease, vol. 2, 256
  6. Halliday, 2000, Perinatal corticosteroid treatment—helpful or harmful, Arch Perinat Med, 6, 7
  7. Halliday, 2001, Guidelines on neonatal steroids, Prenat Neonatal Med, 6, 371

Cited by

See all 51

Metadata

Authors
Grier, D. G., & Halliday, H. L.
Affiliations
Queen's University Belfast (GB)
Corresponding author
Grier, David G
Venue
Seminars in Neonatology
Publisher
Elsevier BV
Published
2003-02
Volume
8
Issue
1
Pages
83-91
ISSN
1084-2756 (ISSN-L)
OpenAlex
W1970918133
Cited by
51
References
60
Citations by year
2025: 1 · 2024: 1 · 2022: 3 · 2021: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Seminars in Neonatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Development and Preterm Care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Keywords
corticosteroids, dexamethasone, bronchopulmonary dysplasia, preterm infants, chronic lung disease, neurodevelopmental outcomes, extubation, lung function, respiratory distress syndrome
MeSH terms
Adrenal Cortex Hormones, Animals, Bronchopulmonary Dysplasia, Dexamethasone, Humans, Infant, Newborn, Infant, Premature, Nervous System Diseases, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Corticosteroids in the prevention and management of bronchopulmonary dysplasia. https://app.cochat.ai/papers/10.1016/s1084-2756(02)00189-6
The paper
Grier, D. G., & Halliday, H. L. (2003). Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Seminars in Neonatology. https://doi.org/10.1016/s1084-2756(02)00189-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.